Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer

Surgery
C M LennardR Michael Tuttle

Abstract

Vascular endothelial growth factor (VEGF) induces proliferation of endothelial cells, stimulates angiogenesis, and increases vascular permeability. Increased VEGF expression has been associated with poor clinical outcomes in many malignancies. Several recent reports have documented over expression of VEGF in papillary thyroid cancer. We hypothesized that increased expression of VEGF would be associated with either an increased risk of recurrence or a decreased recurrence-free survival in papillary thyroid cancer. Immunohistochemistry was used to detect VEGF expression in archival paraffin-embedded surgical thyroid specimens from 96 subjects with papillary thyroid cancer. VEGF expression was detected in 98% (94/96) of the samples, predominantly of slight-to-moderate intensity in the majority of malignant cells. However, the specific finding of a diffuse pattern of intense immunostaining for VEGF was detected significantly more often than less intense, patchy immunostaining patterns in subjects with distant metastasis at diagnosis (63% versus 15%, P =.005), local recurrence (58% versus 13%, P =.001), and distant recurrence (83% versus 14%, P =.001). Furthermore, this specific pattern of diffuse, intense VEGF expression was associ...Continue Reading

References

Sep 30, 1992·Biochemical and Biophysical Research Communications·B I TermanP Böhlen
Nov 1, 1994·The American Journal of Medicine·E L Mazzaferri, S M Jhiang
Jan 15, 1997·Journal of the National Cancer Institute·G GaspariniT Tominaga
Nov 14, 1997·The Journal of Clinical Endocrinology and Metabolism·E Y SohO H Clark
Dec 5, 1998·The International Journal of Biochemistry & Cell Biology·I Zachary
Dec 22, 1999·The Journal of Urology·J JacobsenB Ljungberg

❮ Previous
Next ❯

Citations

Jul 8, 2005·Cancer Chemotherapy and Pharmacology·Ann M StraightGary L Francis
Feb 4, 2005·Langenbeck's Archives of Surgery·Aleksander KonturekWojciech Cichoń
May 20, 2003·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Akkaya Bahar KilicarslanGulten Karpuzoglu
Apr 6, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Steven I Sherman
May 28, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Tamar A GiorgadzeVirginia A Livolsi
May 28, 2002·Journal of Endocrinological Investigation·R Deghenghi
Jul 4, 2008·The New England Journal of Medicine·Steven I ShermanUNKNOWN Motesanib Thyroid Cancer Study Group
Dec 20, 2002·Thyroid : Official Journal of the American Thyroid Association·Andrew J BauerGary L Francis
Jan 10, 2006·Cancer Biotherapy & Radiopharmaceuticals·Jen-Der Lin, Tzu-Chieh Chao
Nov 6, 2009·Thyroid : Official Journal of the American Thyroid Association·Vergilius José Furtado de Araujo-FilhoAlberto R Ferraz
Dec 24, 2011·Thyroid : Official Journal of the American Thyroid Association·Maria D'AgostinoDiego Russo
Sep 26, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Lisa Licitra, Laura D Locati
Jul 16, 2010·Journal of Oncology·Alessandro AntonelliPoupak Fallahi
Apr 25, 2012·Journal of Thyroid Research·Naifa Lamki Busaidy, Maria E Cabanillas
Nov 14, 2012·Therapeutic Advances in Endocrinology and Metabolism·David A Liebner, Manisha H Shah
Aug 23, 2012·PloS One·Anthony K-C SoPaul G Walfish
Sep 17, 2013·Endocrine-related Cancer·John E Phay, Matthew D Ringel
Aug 21, 2012·Biologics : Targets & Therapy·Cesar A PerezEdgardo S Santos
Sep 17, 2008·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Marie RydlovaIvana Stankova
Jun 10, 2011·European Journal of Endocrinology·Cosimo DuranteSebastiano Filetti
Aug 10, 2011·Journal of Thyroid Research·Shannon R Bales, Inder J Chopra
Jul 19, 2011·Journal of Thyroid Research·Natalie BurrowsGeorg Brabant
Aug 8, 2014·Thyroid : Official Journal of the American Thyroid Association·Maria E CabanillasSteven I Sherman
Sep 23, 2014·Critical Reviews in Oncology/hematology·V MarottaA Faggiano
Mar 1, 2012·Expert Review of Anticancer Therapy·Katarina L KojicSam M Wiseman
Apr 8, 2011·Expert Review of Neurotherapeutics·Marc Chamberlain
Jun 13, 2012·Seminars in Radiation Oncology·James Brierley, Eric Sherman
Mar 2, 2016·Nature Reviews. Clinical Oncology·Keith C Bible, Mabel Ryder
May 12, 2010·Critical Reviews in Oncology/hematology·Fabio A B SchutzCora N Sternberg
Feb 23, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lisa LicitraP Bossi
Nov 28, 2009·Best Practice & Research. Clinical Endocrinology & Metabolism·Steven I Sherman
Apr 24, 2009·La Presse médicale·Zelia FrancisMartin Schlumberger
Nov 18, 2008·Hematology/oncology Clinics of North America·Ranee Mehra, Roger B Cohen
Aug 30, 2008·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Alessandro AntonelliPaolo Miccoli
May 27, 2008·Endocrinology and Metabolism Clinics of North America·Steven I Sherman
Nov 15, 2006·Molecular and Cellular Endocrinology·Sebastian HoffmannAndreas Zielke
Feb 14, 2006·Journal of Cellular Biochemistry·Sebastian HoffmannAndreas Zielke
May 6, 2011·Head & Neck·Cesar A PerezEzra E W Cohen
May 31, 2013·Asia-Pacific Journal of Clinical Oncology·Jin LiHonggang Jiang
Nov 13, 2007·Annales d'endocrinologie·L Gautron
Nov 10, 2007·Annales d'endocrinologie·M Klein, B Catargi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.